Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Codexis ( (CDXS) ) is now available.
Codexis, Inc. has appointed Raymond De Vré as a new Class I director to its Board, enhancing its leadership with a seasoned executive experienced in biotech and pharmaceuticals. Dr. De Vré will also join the Science and Technology Committee, bringing expertise from his tenure at RADV Advisory and PolyPeptide Group. Alongside this, Codexis has updated its bylaws to align with Delaware law and refine stockholder meeting procedures, signaling a strategic governance enhancement.
Learn more about CDXS stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue